Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Company has commissioned a new manufacturing facility located at Pithampur, Dist: Dhar, Madhya Pradesh-454774 effective today, for manufacturing of formulations.
APLLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alembic Pharmaceuticals has commissioned a new manufacturing facility at Pithampur, Dist: Dhar, Madhya Pradesh, effective today. The new plant will be used for manufacturing formulations. This is being done under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015. The commissioning represents a capacity expansion move by the company in its formulations business. No specific investment amount or production capacity details have been disclosed in this announcement.
Positive for shareholders as the new facility signals capacity expansion and future revenue growth potential in the formulations segment. The market may react favourably as greenfield plant commissioning typically indicates the company's growth investments are coming to fruition, though the lack of capacity and investment details may limit the immediate upside.